Le Lézard
Classified in: Health, Business

Coleman Institute Withdrawal Management Covered By Anthem Virginia


RICHMOND, Va., July 20, 2018 /PRNewswire-PRWeb/ -- The Coleman Institute, a BayMark Health Services Company, is pleased to announce the acceptance of Anthem Virginia commercial insurance plans for withdrawal management services at the Richmond, VA location. Covered individuals can now participate in both the uniquely comfortable outpatient withdrawal management protocol, also known as detoxification, as well as longer term naltrexone therapy for the treatment of opioid and alcohol use disorders.

"Providing access to life-saving treatment for those struggling with substance use disorders is our primary mission," states Dr. Peter Coleman, Coleman Institute Founder and National Medical Director. "As we secure contracts with insurance providers, we improve our ability to provide that access which is an exciting thing for the Coleman Institute, but more importantly, for our patients."

An innovative center for addiction treatment, The Coleman Institute is a highly effective, medically-supervised detoxification treatment center that does not require hospitalization. The opioid detox program utilizes medication to comfortably and quickly clear opiates from a patient's system. Alcohol detox is a similar process, typically lasting for 3 days and utilizing medications to make patients comfortable and able to safely detoxify their systems. Long term naltrexone therapy is recommended to control cravings and help patients transition from withdrawal management into the long-term program of recovery that is right for them.

The Anthem Virginia contract will provide coverage for the withdrawal management program for opioids and alcohol, as well as for six months of naltrexone therapy and case management services to help patients stay clean and seek the long-term treatment they need for recovery and healing.

For more information on The Coleman Institute in Richmond, VA, please call 804.548.4500 or visit https://thecolemaninstitute.com/

About The Coleman Institute:

Established in 1998 in Richmond, VA, The Coleman Institute has developed a unique and customizable approach to assisting patients in overcoming their physical dependency on drugs and then accessing the long-term support resources needed to maintain their sobriety.

Since its inception, The Coleman Institute has helped thousands of patients detoxify and recover from the effects of heroin use and other opioids such as fentanyl, OxyContin®, Percocet® and Vicodin®. The Coleman Institute's treatment program enables over 98% of its patients to successfully complete their detox and begin Naltrexone therapy. Naltrexone is a non-addictive opiate blocker that helps reduce cravings while patients are building the healthy habits essential for long-term recovery.

The Coleman Institute has 13 offices nationwide. (Richmond, Atlanta, Austin, Southern and Northern California, Cherry Hill, Dallas-Fort Worth, Denver, Indianapolis, Minneapolis-St. Paul, Phoenix, Seattle, Tampa).

 

SOURCE The Coleman Institute


These press releases may also interest you

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...

at 00:39
World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly...

25 avr 2024
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

25 avr 2024
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)



News published on and distributed by: